Bayer ADR logo

Bayer ADR

Stock
Stock
ISIN: US0727303028
Ticker: BAYRY
US0727303028
BAYRY

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 13.05.2025


$0.504

CHART BY

Frequently asked questions

What is Bayer ADR's market capitalization?

The market capitalization of Bayer ADR is $23.70B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Bayer ADR?

Bayer ADR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.272. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Bayer ADR's stock?

Currently, 21 analysts cover Bayer ADR's stock, with a consensus target price of $7.106. Analyst ratings provide insights into the stock's expected performance.

What is Bayer ADR's revenue over the trailing twelve months?

Over the trailing twelve months, Bayer ADR reported a revenue of $53.00B.

What is the EBITDA for Bayer ADR?

Bayer ADR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $12.57B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Bayer ADR?

Bayer ADR has a free cash flow of $4.60B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Bayer ADR have, and what sector and industry does it belong to?

Bayer ADR employs approximately 99,723 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.

What is the free float of Bayer ADR's shares?

The free float of Bayer ADR is 3.93B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$23.70B
EPS (TTM) 
-$0.272
Free Float 
3.93B
Revenue (TTM) 
$53.00B
EBITDA (TTM) 
$12.57B
Free Cashflow (TTM) 
$4.60B

Pricing

1D span
$5.666$5.81
52W span
$4.56$8.742

Analyst Ratings

The price target is $7.106 and the stock is covered by 21 analysts.

Buy

5

Hold

16

Sell

0

Information

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Employees
99,723
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
US0727303028
Primary Ticker
BAYRY

Knockouts

Finance data from FactSet
Join the conversation